The 1,4-dihydropyridine (± )-[3H]nitrendipine reversibly binds to mitochondrial preparations from guineapig heart with a dissociation constant (Kd) 
INTRODUCTION
Some 1 ,4-dihydropyridines [e.g. (± )-nitrendipine, (± )-nimodipine, (-)-azidopine] bind to one of three drug-receptor domains associated with the L-type Ca2" channel having dissociation constants in the nanomolar and subnanomolar range [for reviews, see Triggle & Janis (1987) , Vaghy et al. (1987a) ]. In radiolabelled form these compounds and stpLucturally related analogues have been extensively used in the solubilization and purification of the Ca2"-channel protein (Borsotto et al., 1984; Flockerzi et al., 1986; Curtis & Catterall, 1984; Striessnig et al., 1986) . The photoincorporation of (-)-[3H]azidopine and of [3H]PN (Galizzi et al., 1986) into crude membrane preparations as well as into the purified Ca2"-channel protein (Striessnig et al., 1986; Vaghy et al., 1987b) has led to the identification of the a,-subunit of the L-type Ca2" channel from skeletal muscle (Glossmann et al., 1987; Takahashi et al., 1987) . Recently, the cDNA sequence of this Ca2+-antagonistreceptor-carrying channel polypeptide was reported (Tanabe et al., 1987) . The nanomolar dissociation constants of the 1,4-DHPs in depolarized membrane fragments shift to the micromolar or submicromolar range upon polarization of the preparation, e.g. in intact heart cells (Kokubun et al., 1986) . This membranepotential-induced low-affinity state of the L-type Ca2" channel (Sanguinetti & Kass, 1984; Bean, 1984) is not to be confused with low-affinity 1,4-DHP-binding sites which have been also found in completely depolarized crude membrane preparations (Bellemann et al., 1981 (Bellemann et al., , 1982 Glossmann & Ferry, 1983; Kenessey et al., 1984; Vaghy et al., 1985; Striessnig et al., 1985; Ferry et al., 1987) . 1,4-DHPs bind to these sites with Kd values in the submicromolar range; their density surpasses that of the L-type-Ca2+-channel-associated 1,4-DHP receptors by several orders of magnitude.
These low-affinity 1,4-DHP-binding sites have been characterized with the help of reversible 1,4-DHP binding (Bellemann et al., 1981 (Bellemann et al., , 1982 Glossmann & Ferry, 1983; Vaghy et al., 1985; Ferry et al., 1987; Striessnig et al., 1985; Ruth et al., 1985) , radioligand binding-inhibition by nitrendipine or nifedipine or functional assays (Vaghy et al., 1982; Schaechtele et al., 1987) . Recently, in addition to a 165 kDa protein associated with the L-type Ca2l channel, Ferry et al. (1987) photolabelled 39 kDa and 45 kDa polypeptides with (-)-[3H]azidopine in crude heart membranes. These low-Mr polypeptides were suggested to be the structural equivalent to low-affinity 1,4-DHP-binding sites which did not bind (± )-Bay K 8644, a well-known Ca2l-channel activator. Correspondingly (-)-[3H]nitrendipine (Campbell et al., 1984) or a [1251] iodinated 1,4-dihydropyridine (Sarmiento et al., 1986 ) photolabels polypeptides with molecular masses in the 30-40 kDa range in a variety of tissues, including heart. With the aid of (± )-[3H]nitrendipine we have now physically separated a class of low-affinity 1,4-DHP-binding sites from Ca2l-channel-associated receptors in guinea-pig heart by means of differential and sucrose-gradient centrifugation. We demonstrate below that these low-affinity sites are associated with the mitochondrial inner membrane and are also found on purified mitochondria from liver and kidney. The latter tissues, in contrast with the heart, did not contain 1,4-DHP receptors coupled to the L-type Ca2" channel.
MATERIALS AND METHODS

Materials
Sources of unlabelled calcium-channel ligands were previously given Striessnig et al., 1985; Ferry et al., 1987) . The optical enantiomers of the calcium-channel agonist Bay K 8644, as well as most of the unlabelled 1,4-dihydropyridines, were from Bayer A.G., Wuppertal, Germany. (± )-[3H]Nitrendipine (81.1 Ci/mmol) was from New England Nuclear, Vienna, Austria, and 5-hydroxy[G-3H]tryptamine (20 Ci/mmol) was from Amersham International, Vienna, Austria. All other chemicals were obtained from Merck, Darmstadt, Germany, or Sigma, Munich, Germany, and were of the highest grade available.
Membrane preparation
For sucrose-density-gradient centrifugation, membrane vesicles were prepared from guinea-pig hearts and separated on a 20-40 %-(w/w)-sucrose gradient by isopycnic centrifugation at 100000 g for 15 h at 2°C as described by Vetter et al. (1982) .
Preparation of mitochondria and differential centrifugation were done as described by Matlib et al. (1984) and Reinhart & Bygrave (1981) , with the following modifications. Trimmed ventricles were homogenized with the aid of a Teflon pestle (three bouts of three strokes at 1500 rev./min; all steps were performed at 2°C) in buffer A containing 250 mM-sucrose, 10 mM-Tris/ Hepes, pH 7.4 at 2°C, 1 mM-Tris-EGTA and 0.1 mM-PMSF. Alternatively, buffer B, containing 180 mM-KCl, 1 mM-EGTA and 0.5% (w/v) bovine serum albumin, pH 7.4 at 2°C, was used with the same results. The homogenate was centrifuged at 1000 g for 5 min.
The rotor (rav 10.8 cm) was always operated at 2 'C. The pellet ('iP') was usually discarded and the supernatant ('IS') spun down at 8000 g for 10 min and washed once in buffer A. The resulting pellet was taken up in buffer C, which contained 50 mM-Tris/HCl and 0.1 mM-PMSF pH 7.4 at 2 'C, washed two times in buffer C, and sedimented at 39000 g for 10 min. This final washed pellet was termed '8P', contained the highest specific activity of the mitochondrial enzyme marker, and was used in the binding assays. The combined supernatants from the 8000 g run ('8S') were usually discarded. For localization experiments, they were spun down at 39000 g for 10 min and washed twice in buffer C ('39P'), leaving combined supernatants, termed '39S'.
The submitochondrial localization of (± )-[3H]-nitrendipine-binding sites was determined in the 8P fraction obtained from guinea-pig liver, either by swelling and subsequent sonication of the mitochondria, exactly as described by Sottocasa et al. (1967) or by selective digitonin solubilization as described by Anholt et al. (1986) .
Binding experiments
Unless indicated otherwise, binding of (± )-[3H]-nitrendipine was assayed as follows: membranes (3-22kzg of protein) were incubated with 1.1-3.41nM-(±)-[3H]nitrendipine in a 0.25ml volume of buffer C supplemented with 500 mM-NaCl for 60 min at 37°C, pH 7.4. 'High-affinity binding' was defined as the difference between total binding and binding in presence of 10 /tM-(±)-Bay K 8644 (see Ferry et al., 1987 . In pH-dependencedetermination experiments, buffer C supplemented with 500 mM-NaCl was used in which 50 mM-Tris was replaced by 100 mM-Bistris; the desired pH was obtained by adjustment with HCl at 37 'C. For saturation analysis the specific activity was lowered to 0.76-0.86 Ci/mmol (in four experiments down to 0.008 Ci/mmol) by addition of unlabelled (± )-nitrendipine (or its enantiomers) with overlapping points as described by . Binding experiments with (+)-[3H]PN were performed with 3 #M-(±)-Bay K 8644 as nonspecific-binding control as described by . Binding experiments with (-)-[1251I]iodocyanopindolol were performed as described by Bonacker & Glossmann (1981) with 0.1 mM-(-)-isoprenaline as a non-specific-binding definition. Bound and free ligand were separated by filtration over glass-fibre filters as described by . Briefly, the incubation mixture was diluted with 3.5 ml of ice-cold PEG (10 mM-MgCl2/MgCl2/10 mM-Tris/HCl, pH 7.4) buffer and passed through Whatman GF/C filters under negative pressure, followed by two subsequent washes with 3.5 ml of PEG buffer. Throughout the text below the term 'binding' refers to specific binding of the respective drug.
To assess chemical stability of (±)-[3H]nitrendipine in the binding experiments, 1 nM-(±)-[3H]nitrendipine was incubated with 100 4ug of mitochondrial protein in 0.25 ml of buffer C supplemented with 500 mM-NaCl for 6 h at 37 'C. Bound ligand was separated from unbound ligand by centrifugation and extracted with ethanol. T.l.c. analysis of ethanol-extracted mitochondria-bound (± )-[3H]nitrendipine using a silica-gel support with a chloroform/acetone (95:5, v/v; 25 'C, 2 h) mobile phase showed that more than 95 % of the bound radioactivity co-migrated with unlabelled (± )-nitrendipine or (±)-[3H]nitrendipine incubated for 6 h at 37 'C in the absence of membranes.
Drugs were prepared from 10 mm stock solutions in DMSO. As DMSO proved to be an inhibitor of the lowaffinity (±)-[3Hlnitrendipine-binding site with an IC50 value of4.7 + 0.6% (v/v) (mean + asymptotic S.D., n = 3), its concentration was kept below 0.1 % whenever possible.
Unless indicated otherwise, protein was determined by the method of Lowry et-al. (1951) , with bovine serum albumin as standard. Determination of succinate dehydrogenase and monoamine oxidase Succinate dehydrogenase (EC 1.3.99.1) was assayed as described by King (1967) . The determination of monoamine oxidase (EC 1.4.3.4) activity was performed as described by Fowler & Strolin Benedetti (1983) , with 5-hydroxy[G-3H]tryptamine as substrate and 100 /iMpargyline as blank definition (Lenzen et al., 1983) .
Data analysis
Data from equilibrium binding and kinetic experiments were analysed with the LIGAND program written by Munson & Rodbard (1980) . Binding-competition experiments were analysed as described previously .
RESULTS
Subcellular localization of low-affinity (± )-I3Hlnitrendipine binding sites
When guinea-pig hearts were homogenized and the crude membranes separated on a 20-40 %-(w/w)-sucrose gradient as described by Vetter et al. (1982) , the low- Having established the almost exclusive location of the low-affinity binding sites on mitochondria, we tried to enrich them by differential centrifugation, as the sucrose gradient technique was too time-consuming and the recoveries were low. Fig. 2 shows that tissues, when homogenized under iso-osmotic conditions, yielded a pellet after an 8000g centrifugation step ('8P') which had both the highest specific activity of succinate dehydrogenase and the highest density of low-affinity ( ± ) When mitochondria from the guinea-pig liver 8P fraction were subjected to short hypo-osmotic shock followed by brief sonication (as detailed by Sottocasa et al., 1967) , three different fractions could be separated on a discontinuous sucrose gradient: (a) a soluble fraction at 0.45 M-sucrose, (b) a band at the 0.76/1.32 M-sucrose interface ('light' fraction) and (c) a pellet below the 1.32 M-sucrose layer ('heavy' fraction). As can be seen in Fig. 3 , the heavy fraction contained the highest specific activity of both succinate dehydrogenase and low-affinity (± )-[3H]nitrendipine binding, whereas the light fraction was enriched in monamine oxidase (EC 1.4.3.4) Cardiac membrane vesicles were prepared as described in the Materials and methods section and centrifuged for 15 h at 2°C in a 20-40 %-(w/w)-sucrose gradient at 100000 g. In all, 16 fractions of 2 ml each were recovered. A 100 ,1 portion of each fraction, containing 3-17 ,tg of protein [determined as described by Bradford (1976) ] was incubated in a total volume of 0.25 ml (buffer C supplemented with 500 mM-NaCI) with 2.6 nM-(± (Fig. 7) .
The cation-dependence of low-affinity (± )-[3H]-nitrendipine binding is shown in Fig. 8(a) and Table 1 . In buffer C, (±)-[3H]nitrendipine binding was 0.045 + 0.004 pmol/mg of protein (mean+ S.E.M., n = 5) at a total ligand concentration of 1.1-3.4nm. Enhancement of binding was saturable by (in order of decreasina potency) La3+ > Cd2+ > Co2+ > Ca2+ > Ba2+, whereas Mg2+ > Li+ > Na+ = K+ increased the binding, without reaching saturation, up to the highest concentrations employed.
The anions NO3-> Cl-also increased (±)-[3H]-nitrendipine binding (Fig. 8b, Table 1 ). F-, SO42-, and P043 were without effect in buffer C. However, when tested in buffer C supplemented with 500 mM-NaCl (as used for standard low-affinity binding measurements),
P043-> S042-slightly decreased (± )-[3H]nitrendipine
binding, whereas F-marginally increased it. N03-stimulation in buffer C supplemented with 500 mM-NaCl did not exceed the maximum values attained in buffer C alone (Table 1 The phenylalkylamines were much less potent inhibitors compared with the 1,4-DHPs by a factor of 100 (Table 2) . Again, none of the tested phenylalkylamines displayed any stereoselectivity. Our limited data on phenylalkylamine structure-activity relationships show that (1) both benzene rings are essential for binding -(D619 was ineffective up to 100 SM) and that (2) the number of methoxy groups at one of the two benzene rings does not affect potency (D888, verapamil, D600) .
The benzothiazepines D-and L-cis-diltiazem did not inhibit (±)-[3H]nitrendipine binding in concentrations up to 100 ,UM.
Comparative studies on mitochondrial membranes from liver and kidney showed a similar inhibition profile, despite small differences in potencies. An exception were the enantiomers of PN200-1 10, which did not display stereoselectivity in the two organs. We obtained IC50 values of 1800 nm for (+)-PN200-1 10 and 2200 nm for marker for the mitochondrial inner membrane, and are separated from monoamine oxidase, a marker for the mitochondrial outer membrane. (4) The density of the low-affinity nitrendipine-binding sites in guinea-pig heart mitochondria (1.8 nmol/mg of protein) by far exceeds the density of L-type Ca2l channels in hearts from a variety of species, including the guinea pig, in crude as well as more purified preparations (0.3-1.6pmol/mg of protein; Bellemann et al., 1981; Garcia et al., 1986; Ferry et al., 1987) . This caused considerable problems in photoaffinity and affinity-labelling studies (for a review, see Glossmann et al., 1987 (Glossmann & Ferry, 1983; Vaghy et al., 1985) . (6) The pH-dependence of low-affinity nitrendipine binding is opposite to that of 1,4-dihydropyridine binding to the L-type Ca2" channel . (7) The cations La3" and Co2' enhance low-affinity binding, while inhibiting 1,4-DHP binding to the L-type Ca21 channel Glossmann & Ferry, 1983) . On the other hand, the Ca21 chelator EGTA does not abolish low-affinity (±)-[3H]nitrendipine binding, which is in clear contrast with its effect on the L-type Ca21 channel (Gould et al., 1982; Glossmann et al., 1982; Luchowski et al., 1984) . (8) The beneficial (or toxic) effects of Ca2"-channel drugs cannot be solely explained by their inhibition of the Ca2"-channel activity (Zsoter & Church, 1983) . During oral therapy, 28 % of the low-affinity (±)-[3H]nitrendipine-binding sites could be occupied, rendering them likely candidates for the as-yet-unexplained Ca2+-channel-drug effects [assumptions: peak plasma concentration 70 ng/ml (Raemsch & Sommer, 1984) , equal distribution, Kd 500 nm, intracellular accumulation (Pang & Sperelakis, 1983 , 1984 Liillmann, 1987) not considered].
Seven distinct candidates for low-affinity 1,4-DHPbinding sites have been reported up to now: (1) the nucleoside transporter Ruth et al., 1985) , (2) the Na+/Ca2+ exchanger (Vaghy et al., 1982) , (3) the Na+/K+-ATPase (Pan & Janis, 1984) , (4) the sarcolemmal Ca2+-ATPase (David-Dufilho et al., 1984) , (5) the peripheral benzodiazepine receptor , (6) the calmodulin-dependent cyclic AMP phosphodiesterase (Schaechtele et al., 1987) and (7) the multi-drug-resistance-related membrane glycoprotein gpI50-180 (Cornwell et al., 1987; Safa et al., 1987) . Of these seven candidates, only the Na+/Ca2+ exchanger (for a review, see Carafoli, 1982) and the peripheral benzodiazepine receptor (Anholt et al., 1986) have a reported mitochondrial location; the cyclic AMP phosphodiesterase is not even located in membranes (Nair, 1966 ). None of the tested functional inhibitors of these candidates inhibited (±)-[3H]nitrendipine binding.
In conclusion, the low-affinity (±)-[3H]nitrendipine binding site described here is located in the mitochondrial inner membrane and is clearly distinct from both the 1,4-dihydropyridine-receptor domain of the L-type Ca2" channel as well as all other candidates for low-affinity 1,4-dihydropyridine binding reported so far.
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